Literature DB >> 4860752

Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei.

S B Krantz, V Kao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4860752      PMCID： PMC335662          DOI： 10.1073/pnas.58.2.493

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  THE EFFECT OF ERYTHROPOIETIN UPON HEME SYNTHESIS BY MARROW CELLS IN VITRO.

Authors:  S B KRANTZ; O GALLIEN-LARTIGUE; E GOLDWASSER
Journal:  J Biol Chem       Date:  1963-12       Impact factor: 5.157

2.  Cell antigens and cell specialization. I. A study of blood group antigens on normoblasts.

Authors:  J J YUNIS; E YUNIS
Journal:  Blood       Date:  1963-07       Impact factor: 22.113

3.  Antinuclear factor and other antibodies in blood and liver diseases.

Authors:  E J HOLBOROW; G L ASHERSON; G D JOHNSON; R D BARNES; D S CARMICHAEL
Journal:  Br Med J       Date:  1963-03-09

4.  Immunologic studies on the mechanism of action of erythropoietin.

Authors:  J C SCHOOLEY; J F GARCIA
Journal:  Proc Soc Exp Biol Med       Date:  1962-07

5.  Benign thymoma and selective erythroid aplasia of the bone marrow.

Authors:  E M JACOBS; R V HUTTER; J L POOL; A B LEY
Journal:  Cancer       Date:  1959 Jan-Feb       Impact factor: 6.860

6.  Experimental production of blood disorders in rat by injection of antierythroblastic, antileukoblastic and antimegakaryocytic sera.

Authors:  M BRACCO; P C CURTI; N MASERA
Journal:  Acta Haematol       Date:  1951-08       Impact factor: 2.195

7.  Studies on the effect of anti-bone-marrow-serum.

Authors:  B BJORKLUND; L HELLSTROM
Journal:  Acta Med Scand       Date:  1951

8.  Fluorescent antibody staining. 3. Preparation of fluorescein-isothiocyanate-labeled antibodies.

Authors:  B T Wood; S H Thompson; G Goldstein
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

9.  Erythropoietic effect of plasma from mice receiving testosterone.

Authors:  W Fried; C W Gurney
Journal:  Nature       Date:  1965-06-12       Impact factor: 49.962

10.  The effect of erythropoietin on human bone marrow cells in vitro.

Authors:  S B Krantz
Journal:  Life Sci       Date:  1965-12       Impact factor: 5.037
View more
  20 in total

Review 1.  Current methods for detecting antibodies against erythropoietin and other recombinant proteins.

Authors:  Robin Thorpe; Steven J Swanson
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

2.  Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with anti-erythropoietin-like activity.

Authors:  J H Jepson; L Lowenstein
Journal:  Can Med Assoc J       Date:  1968-07-20       Impact factor: 8.262

3.  Pure red cell aplasia: successful treatment with cyclophosphamide.

Authors:  J Vilan; K Rhyner; A M Ganzoni
Journal:  Blut       Date:  1973-01

4.  The bone marrow in aplastic anaemia: diagnostic and prognostic features.

Authors:  B Frisch; S M Lewis
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

5.  Erythroid aplasia after halothane hepatitis. Report of a case.

Authors:  J C Jurgensen; J P Abraham; W W Hardy
Journal:  Am J Dig Dis       Date:  1970-06

6.  Aplastic anaemia in a patient with pure red cell aplasia.

Authors:  J N McMahon; E L Egan
Journal:  Ir J Med Sci       Date:  1980-05       Impact factor: 1.568

7.  Neutropenia in three patients with rheumatic disorders. Suppression of granulopoiesis by control-sensitive thymus-dependent lymphocytes.

Authors:  G C Bagby; J D Gabourel
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  Serum level of erythropoietin in anemias associated with chronic infection, malignancy, and primary hematopoietic disease.

Authors:  H P Ward; J E Kurnick; M J Pisarczyk
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

9.  Antibody-dependent cellular cytotoxicity to allogeneic but not autologous erythroblasts in vitro.

Authors:  S B Krantz; E N Dessypris
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

10.  Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma.

Authors:  S B Krantz; W H Moore; S D Zaentz
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.